Sumitomo Dainippon Pharma Co Ltd - Strategy, SWOT and Corporate Finance Report

Sumitomo Dainippon Pharma Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co Ltd develops manufactures, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, diabetes, oncology, respiratory psychiatry and neurology and infectious diseases. It also offers veterinary products, research materials, food additives, chemical product materials, food ingredients, diagnostic agents, cosmetic materials and other products. Sumitomo Dainippon has research laboratories, manufacturing and distribution facilities in Japan. The company operates through subsidiaries and offices in the North America, Europe and Asia Pacific. Sumitomo Dainippon is headquartered in Chuo-ku, Osaka, Japan.

Scope

  • Detailed information on Sumitomo Dainippon Pharma Co Ltd required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Sumitomo Dainippon Pharma Co Ltd in the form of a SWOT analysis
  • An in-depth view of the business model of Sumitomo Dainippon Pharma Co Ltd including a breakdown and examination of key business segments
  • News about Sumitomo Dainippon Pharma Co Ltd, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Sumitomo Dainippon Pharma Co Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Sumitomo Dainippon Pharma Co Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Sumitomo Dainippon Pharma Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Tsumura & co

Towa Pharmaceutical Co Ltd

Torii Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Shin-Etsu Chemical Co Ltd

Shin Nippon Biomedical Laboratories Ltd

Nippon ...

Tsumura & co

Towa Pharmaceutical Co Ltd

Torii Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Shin-Etsu Chemical Co Ltd

Shin Nippon Biomedical Laboratories Ltd

Nippon Shinyaku Co Ltd

Mochida Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Kissei Pharmaceutical Co Ltd

Chugai Pharmaceutical Co Ltd

Astellas Pharma Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sumitomo Dainippon Pharma Co Ltd - Key ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sumitomo Dainippon Pharma Co Ltd - Key Facts

Sumitomo Dainippon Pharma Co Ltd - Key Employees

Sumitomo Dainippon Pharma Co Ltd - Key Employee Biographies

Sumitomo Dainippon Pharma Co Ltd - Major Products and Services

Sumitomo Dainippon Pharma Co Ltd - History

Sumitomo Dainippon Pharma Co Ltd - Company Statement

Sumitomo Dainippon Pharma Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Sumitomo Dainippon Pharma Co Ltd - Business Description

Business Segment: Other Business

Overview

Performance

Business Segment: Pharmaceuticals Business

Overview

Performance

Geographical Segment: China

Performance

Geographical Segment: Japan

Performance

Geographical Segment: North America

Performance

Geographical Segment: Other Regions

Performance

R&D Overview

Sumitomo Dainippon Pharma Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Sumitomo Dainippon Pharma Co Ltd - Strengths

Sumitomo Dainippon Pharma Co Ltd - Weaknesses

Sumitomo Dainippon Pharma Co Ltd - Opportunities

Sumitomo Dainippon Pharma Co Ltd - Threats

Sumitomo Dainippon Pharma Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 10, 2019: Sumitomo Dainippon Pharma announces Changes in Board of Directors

May 08, 2019: Sumitomo Dainippon Pharma to Open a New Office for its Regenerative Medicine/Cell Therapy Business in San Diego, U.S.

Apr 11, 2019: Sumitomo Dainippon Pharma announces mid-term business plan 2022

Mar 04, 2019: Sumitomo Dainippon Pharma expands roles and responsibilities of subsidiary in Singapore and establishes subsidiary in Thailand

Oct 30, 2018: Sumitomo Dainippon: Consolidated financial results for the second quarter of the year ending March 31, 2019

Sep 27, 2018: Sumitomo Dainippon Pharma receives the award of Gold Class in Overall Category of SUSTAINA ESG AWARD 2018

Sep 27, 2018: Sumitomo Dainippon Pharma selected as a component of Dow Jones Sustainability Indices DJSI for the second Consecutive Year

Sep 03, 2018: Sumitomo Dainippon Pharma announces personnel changes

Jul 30, 2018: Kyoto University Hospital and the Center for iPS Cell Research and Application (CiRA) to begin physician-initiated clinical trials for parkinson’s disease

Jul 27, 2018: Sumitomo Dainippon Pharma provides summary of consolidated financial results for the first quarter of the year ending March 31, 2019

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Sumitomo Dainippon Pharma Co Ltd, Key Facts

Sumitomo Dainippon Pharma Co Ltd, Key Employees

Sumitomo Dainippon Pharma Co Ltd, Key Employee Biographies ...

List of Tables

Sumitomo Dainippon Pharma Co Ltd, Key Facts

Sumitomo Dainippon Pharma Co Ltd, Key Employees

Sumitomo Dainippon Pharma Co Ltd, Key Employee Biographies

Sumitomo Dainippon Pharma Co Ltd, Major Products and Services

Sumitomo Dainippon Pharma Co Ltd, History

Sumitomo Dainippon Pharma Co Ltd, Other Locations

Sumitomo Dainippon Pharma Co Ltd, Subsidiaries

Sumitomo Dainippon Pharma Co Ltd, Key Competitors

Sumitomo Dainippon Pharma Co Ltd, Ratios based on current share price

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...1)

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...2)

Sumitomo Dainippon Pharma Co Ltd, Interim Ratios

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sumitomo Dainippon Pharma Co Ltd, Performance Chart (2015 - 2019)

Sumitomo Dainippon Pharma Co Ltd, Ratio Charts

Sumitomo Dainippon Pharma Co Ltd, ...

List of Figures

Sumitomo Dainippon Pharma Co Ltd, Performance Chart (2015 - 2019)

Sumitomo Dainippon Pharma Co Ltd, Ratio Charts

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports